Predictive Score of Nodal Involvement in Endometrial Cancer Patients: A Large Multicentre Series
Vito Andrea Capozzi(University of Parma), Roberto Berretta(University of Parma), Massimo Piergiuseppe Franchi(University of Verona), Francesco Fanfani(Agostino Gemelli University Polyclinic), Giovanni Scambia(Agostino Gemelli University Polyclinic), Vito Chiàntera(University of Palermo), Marcello Ceccaroni(Clinical Orthopaedics and Related Research), Giulia Gambino(University of Parma), Giulio Sozzi(University of Palermo), Andrea Rosati(Agostino Gemelli University Polyclinic), Stefano Restaino(University of Udine), Alessandra Cianciolo(University of Parma), Stefano Uccella(University of Insubria)
Cited by 33
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299